版本:
中国

BRIEF-Kitov Pharmaceuticals says signed a license agreement for KIT-302

March 8 Kitov Pharmaceuticals Holdings Ltd

* Kitov Pharmaceuticals Holdings Ltd - has signed a definitive license agreement for its lead product candidate, KIT-302

* Kitov Pharmaceuticals Holdings Ltd - Kuhnil will have exclusive right and license to manufacture, distribute and sell KIT-302 in South Korea

* Kitov Pharmaceuticals Holdings Ltd - Kuhnil will be responsible for seeking regulatory approval for KIT-302 in South Korea

* Kitov Pharmaceuticals Holdings Ltd - commercial launch in South Korea is estimated to take place in 2019

* Kitov Pharmaceuticals Holdings Ltd- under terms of agreement,co is entitled to receive milestone payments and double digit royalties on net sales Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐